Key words: fatty liver, non-alcoholic fatty liver with infl ammation, fructose, rice bran oil, pumpkin seed oil Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease are increasing in adults and are likely to be increasing in children. The aim of the present research was to evaluate the protective effect of rice bran oil and pumpkin seed oil against high fructose diet (HFD) inducing nonalcoholic steatohepatitis (NASH). The results showed signifi cant elevation of plasma total and direct bilirubin, transaminases activities, total cholesterol (T-Ch), triglycerides (TG), low density lipoprotein-cholesterol (LDL-Ch), tumor necrosis factor- (TNF-) and malondialdehyde (MDA) with signifi cant increase in liver TG, T-Ch and MDA along with signifi cant reduction in plasma high density lipoprotein cholesterol (HDL-Ch) and increase in T-Ch/HDL-Ch in rats fed HFD compared to rats fed on balanced diet. Histopathology of liver of rats fed on HFD confi rmed the induction of NASH. Rice bran oil and pumpkin seed oil produced improvement in the biochemical parameters with different degrees. Pumpkin seed oil reversed all histopathological changes that occur in liver tissue which became comparable to normal in some rats. In conclusion, rats fed high fructose diet are a good model for studying NASH. Rice bran oil and pumpkin seed oil afford hepato protection against NASH in rat model.
INTRODUCTION
Fructose is a monosaccharide that is widely available in natural food sources such as fruits and honey. However, in most countries the main source of fructose is from sucrose, a disaccharide composed of equal portions of fructose and glucose. Fructose intake has increased markedly over the last 2 centuries, primarily due to the increasing intake of sucrose and high-fructose corn syrup [Tappy & Le, 2010; Ha et al., 2013] . Fructose is known to stimulate fat accumulation in the liver by both increasing synthesis and blocking fat oxidation [Ackerman et al., 2005] . Therefore, fructose and sugar-sweetened beverages have been related to the risk of non-alcoholic fatty liver disease (NAFLD). Plasma triglycerides are increased by sugar-sweetened beverages, and this increase appears to be due to fructose moiety [Bray, 2012] . NAFLD is the most common hepatic manifestation of obesity, affecting 20%-30% of adults [Neuschwander-Tetri, 2005; Vos & Lavine, 2013] . NAFLD is defi ned as the accumulation of lipid, primarily triacylglycerols, in the liver [McCullough, 2004] . Soft drink consumption was associated with NAFLD independent of metabolic syndrome [Abid et al., 2009] or in the absence of traditional risk factors, including obesity, diabetes or hyperlipidemia [Assy et al., 2008] . In fact, an increasing body of evidence indicates that fructose in the diet itself causes NAFLD [Nomura et al., 2012] .
NAFLD is the most common cause of chronic liver injury worldwide. It has a broad pathologic spectrum which ranges from simple fatty infi ltration of the liver or steatosis, to nonalcoholic steatohepatitis (NASH), fi brosis, cirrhosis and to liver failure [Assy et al., 2000] . NASH is fatty liver with infl ammation and elevated oxidative stress and it is a progressive form of NAFLD that is diagnosed by histopathological features [Brunt et al., 1999] . NAFLD and NASH have been recently recognized as hepatic manifestations of metabolic syndrome [Day & Saksena, 2002] . It has been shown previously that experimental NASH is accompanied by liver dysfunction and dyslipidemia and that NASH is a risk factor for cardiovascular diseases [Al-Okbi et al., 2013] . So, it can be hypothesized that therapy which improves liver function and produces antioxidant, anti-infl ammatory, hypolipidemic and lipotropic effect might prevent progression of NASH and its cardiovascular risk. Based on lack of effective therapies for NASH, natural bioactive constituents from plant materials especially plant foods might be useful in this respect. From such plant foods; rice bran oil and pumpkin seed oil are reported to contain bioactive constituents that might possess the aforementioned activities. Rice bran oil (RBO) is a rich source of bioactive constituents such as oryzanols, phytosterols, tocopherols, tocotrienols, squalene, policosanols and ferulic acid [Khatoon & Gopalakrishna, 2004; Ardiansyah et al., 2006] . These bioactive constituents have been reported to possess multiple health benefi ts including reduction of cholesterol levels [Chen & Cheng, 2006 [Suresh & Das, 2003; Makni et al. 2008 Makni et al. , 2010 . These reported bioactivities of both RBO and pumpkin seed oil could render them potential health benefi t as fatty liver preventives. So the aim of the present study was to evaluate the benefi cial effect of rice bran oil and pumpkin seed oil administration in rats fed high fructose diet inducing NASH. NASH-related biochemical parameters planned to be assessed included liver fat, plasma lipids, TNF-, MDA in both plasma and liver and liver function tests along with histopthological examination of the liver.
MATERIAL AND METHODS

Plant materials
Egyptian rice bran was stabilized after milling by heating at 125°C for 15 min and supplemented by Dr. Amr M. Helal, International Trade & Marketing Managing, Cairo, Egypt. Pumpkin seed oil (Cucurbita pepo L., Family Cucurbitaceae var. styria) was obtained from Graz, Austria.
Animals
Male Sprague Dawley rats of body weight equal to 160.3±15.13 g as mean±SD were used in the present study. Animals were obtained from Animal House of National Research Centre, Cairo, Egypt. Animals were kept individually in stainless steel cages; water and food were given ad-libtium.
Preparation of plant extracts
Rice bran was subjected to continuous extraction by petroleum ether (40-60°C) using Soxhlet apparatus to prepare the oil. The solvent was completely removed by evaporation under reduced pressure at a temperature not exceeding 40°C. The oil yield was 18.4%.
Diets
Experimental diets were prepared in powder form and their composition was shown in Table 1 . High fructose diet was prepared similarly to Kawasaki et al. [2009] to induce NASH (nonalcoholic fatty liver with infl ammation).
Experimental procedures
Twenty-four rats were divided into four groups, each of six rats. The fi rst was normal group where rats received a balanced diet. The second group was control where rats were fed on high fructose diet (for induction of NASH). Rats of group three and four were fed on high fructose diet containing rice bran oil and pumpkin seed oil and also given an oral daily dose of 200 mg/rat/day of rice bran oil and pumpkin seed oil, respectively. During the experiment, body weight and food intake were recorded weekly. After thirty-fi ve days (end of the study) total food intake, body weight gain and food effi ciency ratio (body weight gain/total food intake) were calculated. Blood samples were collected from eye orbital of anaesthetized rats after an overnight fast. Heparin was added to blood and plasma was separated by centrifugation at 3000 rpm. Plasma total cholesterol (T-Ch) [Watson, 1960] , high density lipoprotein cholesterol (HDL-Ch) [Burstein et al., 1970] , low density lipoprotein cholesterol (LDL-Ch) [Schriewer et al., 1984] and triglycerides (TG) [Megraw et al., 1979] were determined. The T-Ch / HDL-Ch ratio was calculated. Malondialdehyde (MDA) was determined as an indicator of lipid peroxidation [Satoh, 1978] . Plasma tumor necrosis factor- (TNF-) (an infl ammatory biomarker) [Stepaniak et al., 1995] was determined. The activity of aspartate transaminase (AST) and alanine transaminase (ALT) [Reitman & Frankel, 1957] was estimated as indicators of liver function and/or damage. Liver was immediately removed, weighed and stored at -20°C till analyzed. Total hepatic lipids were extracted and weighed according to the procedure of Folch et al. [1957] and the concentration of triglycerides and cholesterol assessed [Megraw et al., 1979 and Watson, 1960 , respectively]. MDA was determined in the liver according to Ohkawa et al. [1979] . For histopathological study, part of liver was removed, placed in 10% formaldehyde, dehydrated in graded alcohol and embedded in paraffi n. Fine sections were prepared, mounted on glass slides and counter-stained with hematoxylin and eosin for light microscopic analysis [Ekor et al., 2010] . Animal procedures were performed in accordance with the Ethics Committee of the National Research Centre, Cairo, Egypt, and followed the recommendations of the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-23, revised 1985).
Statistical analysis
The results of animal experiments are expressed as the mean±SE and they are analyzed statistically using the one-way analysis of variance ANOVA followed by Duncan's test. In all cases p<0.05 was used as the criterion of statistical signifi cance. Table 2 showed different biochemical parameters of different experimental groups. Plasma levels of total and direct bilirubin and plasma activities of AST and ALT were increased signifi cantly in HFD-fed rats, indicating liver dysfunction. Treatment with rice bran oil or pumpkin seed oil with HFD resulted in signifi cant reduction of AST and ALT activity and decreased levels of total and direct bilirubin compared to the HFD-fed rats without treatment. HFD-fed rats exhibited a signifi cant increase in plasma total cholesterol, triglycerides, LDL-Ch and the ratio of T-Ch/HDL-Ch compared to control rats. In addition, signifi cant increases were observed in total fat, T-Ch and TG in the liver tissue of HFD-fed rats compared to control normal. Rats treated with rice bran oil or pumpkin seed oil showed signifi cant improvement in plasma lipid profi le and the contents of liver total fat, T-Ch and TG with different degrees. Plasma and liver levels of MDA increased signifi cantly in HFD rats compared to normal control. Rats fed on HFD and treated with rice bran oil or pumpkin seed oil showed signifi cant reduction in MDA levels but still higher than normal rats. Plasma level of TNF- was signifi cantly higher in HFD group than in normal rats. This elevation was reduced signifi cantly in rats fed on HFD and treated with rice bran oil or pumpkin seed oil. Nutritional parameters of normal and fatty liver rats are shown in Table 3 . The results revealed that non-signifi cant changes were noticed in fi nal body weight and body weight gain, whereas the total food intake was signifi cantly higher in fatty liver rats, with or without treatment with the tested oils, in comparison with the normal rats. Rats fed on HFD and treated with rice bran oil or pumpkin seed oil showed signifi cant reduction in the food effi ciency ratio compared with normal control and high fructose control. Liver weight/ body weight % showed signifi cant reduction when the control group fed the balanced diet was compared with the other groups. Figure 1 (a-h) showed sections of liver of different experimental groups. It can be noticed that liver of rats fed on balanced diet (Figure 1 a) has normal appearance, the hepatocytes run in trabeculae of normal thickness, without infl ammatory cell collections or other changes. Figure 1 (b, c) showed that liver of rats fed on high fructose diet was characterized by fatty changes or steatosis with variable sized intracellular fat vacuoles (macro and microvesicular steatosis). Also collections of necro-infl ammatory foci within the liver lobules were noticed. The effect was variable within the rats, with most of them showing severe changes. The accumulations of fat along with infl ammation in the liver refl ect the occurrence of NASH.
RESULTS
Liver histopathology
Liver of rats given rice bran oil (Figure1 d, e) during feeding with the high fructose diet showed that the fat vacuoles and the infl ammation were generally lesser than in the fatty liver of control group, however the changes were variable ranging from moderate to mild. Liver of rats given pumpkin seed oil (Figure1 f, g & h) during feeding with the high fructose diet showed fatty changes and infl ammation much lesser than the control fatty liver group, the changes ranged from moderate to mild, moreover some rats showed liver with almost normal features.
DISCUSSION
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury in many countries around the world. It has a broad pathologic spectrum which ranges from simple fatty infi ltration of the liver or steatosis, to nonalcoholic steatohepatitis (NASH), fi brosis, cirrhosis and to liver failure. NASH is considered as one of the risk factors for cardiovascular diseases including arteriosclerosis where elevation of oxidative stress, infl ammation and levels of plasma TG, LDL-Ch and total cholesterol result from the increased synthesis and accumulation of cholesterol and fat in liver during NASH [Al- Okbi et al., 2013] . Studies have shown that the intake of high fructose diet results in insulin resistance (IR), hepatic steatosis, excessive generation of reactive oxygen species (ROS), malfunctioning of the liver and depletion of the hepatocyte population [Jaya & Amuradha, 2010] . There is evidence that oxidative stress contributes to the development of steatohepatitis from steatosis induced by high-energy diet [Barbuio et al., 2007] . A body of evidence indicates that accumulation of fat in the liver increases the susceptibility to other insults such as oxidative stress and subsequent infl ammation that results in the progression of steatosis to steatohepatitis, fi brosis and cirrhosis [Koteish & Diehl, 2001 ]. Induction of oxidative stress in the present study was evident from the increased plasma and liver MDA, the lipid peroxidation biomarkers in the control rats fed HFD. Also, the HFD-fed rats showed increased level of infl ammatory biomarker TNF-. HFD feeding was associated with hepatocellular damage and microvesicular steatosis and infl ammation as shown from the histopathological results of the present study. The increases in plasma levels of total and direct bilirubin and activities of AST and ALT confi rmed the induced liver injury by histopathology. Rice bran oil and pumpkin oil could effectively protect against the hepatic oxidative stress and infl ammation induced by HFD which is manifested by reduction of MDA and TNF-. Treatment with rice bran oil and pumpkin seed oil notably prevented the elevation of liver enzymes as shown from the results and which is supported by prevention of liver cell damage and preserving cell integrity as seen from liver histology possibly leading to maintenance of the functionally of active cells.
The contents of total lipids, cholesterol and TG were signifi cantly elevated in liver of HFD fed rats, which is a serious risk factor for the development of steatohepatities and liver injury. Results of the histopathological examination of liver of HFD-fed rats showed widespread deposition of lipid droplets inside the parenchymal cells which are consistent with the result of the biochemical analysis of fat. Evidence of lipid accumulation in liver exposed to HFD has been reported previously [Aragno et al., 2009] . Fructose is highly lipogeneic, so HFD used in this study might result in the increased delivery of fatty acids through the portal circulation together with increasing liver fat synthesis resulting in fatty liver. Lipid dysregulation in fructose-fed rat model has been associated to the activation of oxidative stress and infl ammatory pathways in the liver which favors the progression to NAFLD [Basciano et al., 2005] . An evolving hypothesis is that metabolic disease, ROS formation and infl ammation create a progressive cycle leading to disease progression and NAFLD [Raval et al., 2006] . Treatment of HFD-fed rats with rice bran oil and pumpkin seed oil showed considerable reduction of liver fats which together with the reduction of oxidative stress shown by malondialdehyde inhibition may lead to the prevention of NASH.
Recent studies have demonstrated that ingestion of vegetable polyunsaturated fatty acids is inversely related to the incidence of heart disease by decreasing plasma cholesterol and triacylglycerol [Vijaimohan et al., 2006] . The present results indicated that both rice bran oil and pumpkin seed oil rich in polyunsaturated fatty acids produced reduction in triglycerides and cholesterol in both plasma and liver of rats with a reduction of plasma LDL-Ch and an increase in HDL-Ch. Furthermore, the atherogenic index markedly decreased due to signifi cant reduction in T-Ch/HDL-Ch ratio in both groups fed HFD supplemented with either rice bran oil or pumpkin seed oil. Feoli et al. [2003] stated that the increase in HDL-Ch is one of the most important criteria of anti-hypercholesterolemic activity.
The insignifi cant change in body weight gain between rats given high fructose diet without treatment and these given the balanced diet agreed with the work of Kawasaki et al. [2009] that proved induction of fatty liver without change in body weight. Final body weight and body weight gain reduced insignifi cantly in rats fed on HFD and treated with rice bran oil or pumpkin seed oil compared to control rats fed HFD. It has been reported previously that there is a positive correlation between body weight and plasma triglycerides [Howard et al., 1983] . It can be noticed that administration of rice bran oil or pumpkin seed oil induced signifi cant reduction in TG which may explain the reduced body weight. The signifi cant increase of Liver weight/body weight% in rats fed on HFD compared to those fed balanced diet might be due to increased fat deposition in the liver in those rats as shown from the present results. The reduction of Liver weight/body weight% in rats fed on HFD and treated with rice bran or pumpkin seed oil might be ascribed to the signifi cant reduction of liver fat compared to those fed HFD.
The protective effect of rice bran oil and pumpkin seed oil against fatty liver progression may be attributed to the presence of biologically-active compounds. Pumpkin seed oil contains phenolic compounds, tocopherol, -carotene, unsaturated fatty acids and sterols [Al-Okbi et al., in press]. The major total fatty acids present in rice bran oil and pumpkin oil are unsaturated fatty acids such as oleic acid and linoleic acid [Chopra & Sambaiah, 2009 ; Al-Okbi et al., in press]. These unsaturated fatty acids play a crucial role in reducing blood cholesterol in humans and rats [Barakat & Mahmoud, 2011] which might be related to reduction of cholesterol synthesis and/or increased cholesterol catabolism in the liver.
Rice bran oil is rich in an array of bio-active phytochemicals such as -oryzanols, phytosterols, tocopherols, tocotrienols, squalene, policosanols ferulic acid and unsaturated fatty acids [Khatoon & Gopalakrishna, 2004; Ardiansyah et al., 2006] . It was reported by Al-Okbi et al. [in press ] that Egyptian rice bran oil, used in the present study, contains stigmasterol, campesterol and -sitosterol as 12% of unsaponifiable matter. It also contains -carotene at 225 μg/100g oil, -tocopherol at 665 μg/g, -tocopherol at 70 μg/g, while -tocopherol was 172 μg/g oil. Alpha,  and -tocotrienol concentrations were found to be 119, 183 and 8.24 μg/g in rice bran oil, respectively. Gamma-oryzanol content of the same rice bran oil was 3.33 g/100 g. Total policosanol was present in rice bran oil at 69.62 mg/100 g [Al-Okbi et al., in press]. So, rice bran is a rich natural source of vitamin E [Saunders, 1985] . Gamma-oryzanol, which is a mixture of 10 ferulate esters of triterpene alcohol [Lloyd et al., 2000] , has been reported to contribute to multiple health benefi ts, including, reduction of cholesterol levels [Chen & Cheng, 2006] , antioxidant functions [Xu et al., 2001] and anti-infl ammatory activity [Akihisa et al., 2000] . The high contents of -oryzanol and -tocotrienols in rice bran oil can lead to increased fecal neutral sterol and bile acid excretion, via upregulation of cholesterol synthesis and catabolism [Chen & Cheng, 2006; Wilson et al., 2007] in the liver. Nagasaka et al. [2007] reported that -oryzanol suppressed NF-ĸB activation, inhibited infl ammatory responses of macrophage cell line and that -oryzanol increased adiponectin secretion from adipocyte [Ohara et al., 2009] . So, these effects might be responsible for reduction of fatty liver and its progression to steatohepatitis. In a recent study, Fang et al. [2010] established that tocotrienol from rice bran oil functioned as PPAR (peroxisome proliferator activated receptors) modulators and improved whole body glucose utilization and insulin sensitivity of diabetic Db/ Db mice by selectively regulating PPAR target genes. Hence, this effect may also contribute to the inhibition of the incidence of fatty liver.
Pumpkin seed is a rich natural source of proteins, phytosterols, polyunsaturated fatty acids, antioxidant vitamins such as carotenoids and tocopherol [Stevenson et al., 2007] , which possess signifi cant antioxidant activity, anti-infl ammatory and hypolipidemic effects [Suresh & Das, 2003 ]. Pumpkin seed oil used in the present study showed previously to contain 3.5% of oleic acid, 38.9% of linoleic acid and 5.8% of palmitic acid [Al-Okbi et al., 2014] . The same pumpkin seed oil contains stigmasterol and campesterol as 43.6% of unsaponifi able portion. It also contains  and -tocopherol in addition to 28.5μg of -carotene/100 g oil [Al-Okbi et al., 2014] . Phenolic compounds were present in the same pumpkin seed oil at 14.033 mg GAE/g [Al-Okbi et al., 2014]. The hypolipidemic, antioxidant, anti-infl ammatory and liver lipid lowering effects of pumpkin seed oil in the present study are certainly attributed to the presence of the aforementioned bioactive constituents. These components might also reduce the progression of fatty liver to NASH. Makni et al. [2008 Makni et al. [ , 2010 demonstrated that fl ax and pumpkin seed mixture supplemented to diet of hypercholesterolemic rats had a signifi cant anti-atherogenic, hypolipidemic and antioxidant potency.
CONCLUSIONS
Rats fed the high fructose diet are a good model for studying NASH. Rice bran oil and pumpkin seed oil afford hepato protection against NASH in rat model.
